Neovasc Announces LeMaitre Vascular will Accelerate its Acquisition of Rights to In-House Manufacture of XenoSure Product

Neovasc Announces LeMaitre Vascular will Accelerate its Acquisition of Rights to In-House Manufacture of XenoSure Product

[at noodls] – NEWS RELEASE TSX Venture Exchange: NVC 13700 Mayfield Place, Suite 2135 Richmond BC V6V 2E4 Canada P:604.270.4344 F:604.270.4384 www.neovasc.com NEOVASC INC. ANNOUNCES LEMAITRE VASCULAR WILL ACCELERATE … more

View todays social media effects on LMAT

View the latest stocks trending across Twitter. Click to view dashboard

Share this post